nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—TNF—malignant glioma	0.396	0.678	CbGaD
Pomalidomide—PTGS2—malignant glioma	0.188	0.322	CbGaD
Pomalidomide—CYP1A2—Carmustine—malignant glioma	0.116	0.569	CbGbCtD
Pomalidomide—CYP3A4—Temozolomide—malignant glioma	0.0879	0.43	CbGbCtD
Pomalidomide—Pneumocystis jirovecii pneumonia—Temozolomide—malignant glioma	0.01	0.101	CcSEcCtD
Pomalidomide—Teratogenicity—Carmustine—malignant glioma	0.00621	0.0627	CcSEcCtD
Pomalidomide—Altered state of consciousness—Temozolomide—malignant glioma	0.00272	0.0275	CcSEcCtD
Pomalidomide—Lymphopenia—Temozolomide—malignant glioma	0.00246	0.0248	CcSEcCtD
Pomalidomide—Febrile neutropenia—Carmustine—malignant glioma	0.00216	0.0218	CcSEcCtD
Pomalidomide—Febrile neutropenia—Temozolomide—malignant glioma	0.00209	0.0211	CcSEcCtD
Pomalidomide—Deep vein thrombosis—Temozolomide—malignant glioma	0.00207	0.0209	CcSEcCtD
Pomalidomide—Embolism—Temozolomide—malignant glioma	0.00196	0.0198	CcSEcCtD
Pomalidomide—Interstitial lung disease—Carmustine—malignant glioma	0.00184	0.0186	CcSEcCtD
Pomalidomide—Interstitial lung disease—Temozolomide—malignant glioma	0.00178	0.0179	CcSEcCtD
Pomalidomide—CRBN—embryo—malignant glioma	0.00157	0.106	CbGeAlD
Pomalidomide—Thalidomide—TNF—malignant glioma	0.00143	0.323	CrCbGaD
Pomalidomide—CRBN—retina—malignant glioma	0.00139	0.0939	CbGeAlD
Pomalidomide—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00138	0.014	CcSEcCtD
Pomalidomide—Pulmonary embolism—Carmustine—malignant glioma	0.0013	0.0131	CcSEcCtD
Pomalidomide—CRBN—telencephalon—malignant glioma	0.00127	0.0864	CbGeAlD
Pomalidomide—Musculoskeletal pain—Temozolomide—malignant glioma	0.00127	0.0128	CcSEcCtD
Pomalidomide—Pulmonary embolism—Temozolomide—malignant glioma	0.00126	0.0127	CcSEcCtD
Pomalidomide—Depressed level of consciousness—Carmustine—malignant glioma	0.00126	0.0127	CcSEcCtD
Pomalidomide—Neuropathy—Carmustine—malignant glioma	0.00122	0.0123	CcSEcCtD
Pomalidomide—Depressed level of consciousness—Temozolomide—malignant glioma	0.00121	0.0123	CcSEcCtD
Pomalidomide—Thalidomide—PTGS1—malignant glioma	0.00119	0.268	CrCbGaD
Pomalidomide—Neuropathy—Temozolomide—malignant glioma	0.00118	0.0119	CcSEcCtD
Pomalidomide—Lenalidomide—PTGS2—malignant glioma	0.00114	0.256	CrCbGaD
Pomalidomide—Sepsis—Carmustine—malignant glioma	0.00113	0.0114	CcSEcCtD
Pomalidomide—CRBN—medulla oblongata—malignant glioma	0.001	0.0679	CbGeAlD
Pomalidomide—Hyponatraemia—Carmustine—malignant glioma	0.000948	0.00957	CcSEcCtD
Pomalidomide—CRBN—midbrain—malignant glioma	0.000915	0.062	CbGeAlD
Pomalidomide—CRBN—spinal cord—malignant glioma	0.000893	0.0605	CbGeAlD
Pomalidomide—Hypokalaemia—Carmustine—malignant glioma	0.000859	0.00868	CcSEcCtD
Pomalidomide—Dehydration—Temozolomide—malignant glioma	0.000849	0.00857	CcSEcCtD
Pomalidomide—Dry skin—Temozolomide—malignant glioma	0.000836	0.00845	CcSEcCtD
Pomalidomide—Muscular weakness—Carmustine—malignant glioma	0.000833	0.00841	CcSEcCtD
Pomalidomide—Hypokalaemia—Temozolomide—malignant glioma	0.00083	0.00839	CcSEcCtD
Pomalidomide—Breast disorder—Temozolomide—malignant glioma	0.000825	0.00833	CcSEcCtD
Pomalidomide—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000805	0.00813	CcSEcCtD
Pomalidomide—Muscular weakness—Temozolomide—malignant glioma	0.000805	0.00813	CcSEcCtD
Pomalidomide—PTGS2—endothelium—malignant glioma	0.000776	0.0526	CbGeAlD
Pomalidomide—Pancytopenia—Carmustine—malignant glioma	0.000775	0.00783	CcSEcCtD
Pomalidomide—Neutropenia—Carmustine—malignant glioma	0.000763	0.00771	CcSEcCtD
Pomalidomide—Bronchitis—Temozolomide—malignant glioma	0.000758	0.00766	CcSEcCtD
Pomalidomide—Pancytopenia—Temozolomide—malignant glioma	0.000749	0.00756	CcSEcCtD
Pomalidomide—Neutropenia—Temozolomide—malignant glioma	0.000737	0.00745	CcSEcCtD
Pomalidomide—Hyperglycaemia—Carmustine—malignant glioma	0.000736	0.00743	CcSEcCtD
Pomalidomide—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000733	0.0074	CcSEcCtD
Pomalidomide—Pneumonia—Carmustine—malignant glioma	0.000732	0.00739	CcSEcCtD
Pomalidomide—CRBN—central nervous system—malignant glioma	0.000725	0.0491	CbGeAlD
Pomalidomide—Weight increased—Temozolomide—malignant glioma	0.000718	0.00725	CcSEcCtD
Pomalidomide—PTGS2—blood vessel—malignant glioma	0.000715	0.0485	CbGeAlD
Pomalidomide—Renal failure—Carmustine—malignant glioma	0.000715	0.00722	CcSEcCtD
Pomalidomide—Weight decreased—Temozolomide—malignant glioma	0.000713	0.00721	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Carmustine—malignant glioma	0.000713	0.0072	CcSEcCtD
Pomalidomide—Hyperglycaemia—Temozolomide—malignant glioma	0.000711	0.00718	CcSEcCtD
Pomalidomide—CRBN—cerebellum—malignant glioma	0.000708	0.048	CbGeAlD
Pomalidomide—Urinary tract infection—Carmustine—malignant glioma	0.000707	0.00714	CcSEcCtD
Pomalidomide—Pneumonia—Temozolomide—malignant glioma	0.000707	0.00714	CcSEcCtD
Pomalidomide—Infestation NOS—Temozolomide—malignant glioma	0.000703	0.0071	CcSEcCtD
Pomalidomide—Infestation—Temozolomide—malignant glioma	0.000703	0.0071	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Temozolomide—malignant glioma	0.000689	0.00696	CcSEcCtD
Pomalidomide—Urinary tract infection—Temozolomide—malignant glioma	0.000683	0.0069	CcSEcCtD
Pomalidomide—Thalidomide—PTGS2—malignant glioma	0.000681	0.153	CrCbGaD
Pomalidomide—Hepatobiliary disease—Temozolomide—malignant glioma	0.000665	0.00672	CcSEcCtD
Pomalidomide—Oedema peripheral—Carmustine—malignant glioma	0.000643	0.0065	CcSEcCtD
Pomalidomide—Connective tissue disorder—Carmustine—malignant glioma	0.000642	0.00648	CcSEcCtD
Pomalidomide—Urinary tract disorder—Temozolomide—malignant glioma	0.000623	0.0063	CcSEcCtD
Pomalidomide—Oedema peripheral—Temozolomide—malignant glioma	0.000622	0.00628	CcSEcCtD
Pomalidomide—Connective tissue disorder—Temozolomide—malignant glioma	0.00062	0.00626	CcSEcCtD
Pomalidomide—Urethral disorder—Temozolomide—malignant glioma	0.000619	0.00625	CcSEcCtD
Pomalidomide—Cardiac disorder—Temozolomide—malignant glioma	0.000586	0.00592	CcSEcCtD
Pomalidomide—CRBN—brain—malignant glioma	0.000575	0.039	CbGeAlD
Pomalidomide—Angiopathy—Temozolomide—malignant glioma	0.000573	0.00578	CcSEcCtD
Pomalidomide—Mental disorder—Carmustine—malignant glioma	0.000572	0.00578	CcSEcCtD
Pomalidomide—Mediastinal disorder—Temozolomide—malignant glioma	0.000569	0.00575	CcSEcCtD
Pomalidomide—Malnutrition—Carmustine—malignant glioma	0.000569	0.00574	CcSEcCtD
Pomalidomide—Chills—Temozolomide—malignant glioma	0.000566	0.00572	CcSEcCtD
Pomalidomide—Mental disorder—Temozolomide—malignant glioma	0.000553	0.00558	CcSEcCtD
Pomalidomide—Back pain—Carmustine—malignant glioma	0.00055	0.00555	CcSEcCtD
Pomalidomide—Malnutrition—Temozolomide—malignant glioma	0.000549	0.00555	CcSEcCtD
Pomalidomide—Tremor—Carmustine—malignant glioma	0.000533	0.00538	CcSEcCtD
Pomalidomide—Back pain—Temozolomide—malignant glioma	0.000532	0.00537	CcSEcCtD
Pomalidomide—Anaemia—Carmustine—malignant glioma	0.000526	0.00531	CcSEcCtD
Pomalidomide—Tremor—Temozolomide—malignant glioma	0.000515	0.0052	CcSEcCtD
Pomalidomide—Leukopenia—Carmustine—malignant glioma	0.000509	0.00514	CcSEcCtD
Pomalidomide—Anaemia—Temozolomide—malignant glioma	0.000508	0.00513	CcSEcCtD
Pomalidomide—Vertigo—Temozolomide—malignant glioma	0.000494	0.00499	CcSEcCtD
Pomalidomide—Leukopenia—Temozolomide—malignant glioma	0.000492	0.00497	CcSEcCtD
Pomalidomide—Anxiety—Carmustine—malignant glioma	0.000482	0.00487	CcSEcCtD
Pomalidomide—Cough—Temozolomide—malignant glioma	0.00048	0.00484	CcSEcCtD
Pomalidomide—Confusional state—Carmustine—malignant glioma	0.000468	0.00473	CcSEcCtD
Pomalidomide—Arthralgia—Temozolomide—malignant glioma	0.000468	0.00472	CcSEcCtD
Pomalidomide—Anxiety—Temozolomide—malignant glioma	0.000466	0.00471	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000465	0.00469	CcSEcCtD
Pomalidomide—Infection—Carmustine—malignant glioma	0.000461	0.00466	CcSEcCtD
Pomalidomide—Thrombocytopenia—Carmustine—malignant glioma	0.000454	0.00459	CcSEcCtD
Pomalidomide—Confusional state—Temozolomide—malignant glioma	0.000452	0.00457	CcSEcCtD
Pomalidomide—Infection—Temozolomide—malignant glioma	0.000446	0.0045	CcSEcCtD
Pomalidomide—ABCB1—blood vessel—malignant glioma	0.000443	0.03	CbGeAlD
Pomalidomide—Nervous system disorder—Temozolomide—malignant glioma	0.00044	0.00444	CcSEcCtD
Pomalidomide—Thrombocytopenia—Temozolomide—malignant glioma	0.000439	0.00443	CcSEcCtD
Pomalidomide—Skin disorder—Temozolomide—malignant glioma	0.000436	0.0044	CcSEcCtD
Pomalidomide—Hyperhidrosis—Temozolomide—malignant glioma	0.000434	0.00438	CcSEcCtD
Pomalidomide—PTGS2—embryo—malignant glioma	0.000427	0.0289	CbGeAlD
Pomalidomide—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000423	0.00427	CcSEcCtD
Pomalidomide—Insomnia—Carmustine—malignant glioma	0.00042	0.00424	CcSEcCtD
Pomalidomide—Dyspnoea—Carmustine—malignant glioma	0.000414	0.00418	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000409	0.00413	CcSEcCtD
Pomalidomide—Insomnia—Temozolomide—malignant glioma	0.000406	0.0041	CcSEcCtD
Pomalidomide—Decreased appetite—Carmustine—malignant glioma	0.000403	0.00407	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Carmustine—malignant glioma	0.000401	0.00405	CcSEcCtD
Pomalidomide—Dyspnoea—Temozolomide—malignant glioma	0.0004	0.00404	CcSEcCtD
Pomalidomide—Constipation—Carmustine—malignant glioma	0.000397	0.00401	CcSEcCtD
Pomalidomide—Pain—Carmustine—malignant glioma	0.000397	0.00401	CcSEcCtD
Pomalidomide—Decreased appetite—Temozolomide—malignant glioma	0.00039	0.00394	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000387	0.00391	CcSEcCtD
Pomalidomide—Fatigue—Temozolomide—malignant glioma	0.000387	0.0039	CcSEcCtD
Pomalidomide—Pain—Temozolomide—malignant glioma	0.000384	0.00387	CcSEcCtD
Pomalidomide—Constipation—Temozolomide—malignant glioma	0.000384	0.00387	CcSEcCtD
Pomalidomide—Feeling abnormal—Carmustine—malignant glioma	0.000382	0.00386	CcSEcCtD
Pomalidomide—Feeling abnormal—Temozolomide—malignant glioma	0.00037	0.00373	CcSEcCtD
Pomalidomide—Body temperature increased—Carmustine—malignant glioma	0.000367	0.0037	CcSEcCtD
Pomalidomide—Body temperature increased—Temozolomide—malignant glioma	0.000355	0.00358	CcSEcCtD
Pomalidomide—PTGS2—telencephalon—malignant glioma	0.000347	0.0235	CbGeAlD
Pomalidomide—Hypersensitivity—Carmustine—malignant glioma	0.000342	0.00345	CcSEcCtD
Pomalidomide—Asthenia—Carmustine—malignant glioma	0.000333	0.00336	CcSEcCtD
Pomalidomide—Hypersensitivity—Temozolomide—malignant glioma	0.00033	0.00334	CcSEcCtD
Pomalidomide—Asthenia—Temozolomide—malignant glioma	0.000322	0.00325	CcSEcCtD
Pomalidomide—Diarrhoea—Carmustine—malignant glioma	0.000318	0.00321	CcSEcCtD
Pomalidomide—Pruritus—Temozolomide—malignant glioma	0.000317	0.0032	CcSEcCtD
Pomalidomide—Dizziness—Carmustine—malignant glioma	0.000307	0.0031	CcSEcCtD
Pomalidomide—Diarrhoea—Temozolomide—malignant glioma	0.000307	0.0031	CcSEcCtD
Pomalidomide—Dizziness—Temozolomide—malignant glioma	0.000297	0.00299	CcSEcCtD
Pomalidomide—Vomiting—Carmustine—malignant glioma	0.000295	0.00298	CcSEcCtD
Pomalidomide—Rash—Carmustine—malignant glioma	0.000293	0.00295	CcSEcCtD
Pomalidomide—Dermatitis—Carmustine—malignant glioma	0.000292	0.00295	CcSEcCtD
Pomalidomide—Headache—Carmustine—malignant glioma	0.000291	0.00294	CcSEcCtD
Pomalidomide—Vomiting—Temozolomide—malignant glioma	0.000285	0.00288	CcSEcCtD
Pomalidomide—Rash—Temozolomide—malignant glioma	0.000283	0.00286	CcSEcCtD
Pomalidomide—Dermatitis—Temozolomide—malignant glioma	0.000283	0.00285	CcSEcCtD
Pomalidomide—Headache—Temozolomide—malignant glioma	0.000281	0.00284	CcSEcCtD
Pomalidomide—Nausea—Carmustine—malignant glioma	0.000276	0.00278	CcSEcCtD
Pomalidomide—PTGS2—medulla oblongata—malignant glioma	0.000273	0.0185	CbGeAlD
Pomalidomide—Nausea—Temozolomide—malignant glioma	0.000266	0.00269	CcSEcCtD
Pomalidomide—ABCB1—embryo—malignant glioma	0.000264	0.0179	CbGeAlD
Pomalidomide—PTGS2—midbrain—malignant glioma	0.000249	0.0169	CbGeAlD
Pomalidomide—PTGS2—spinal cord—malignant glioma	0.000243	0.0165	CbGeAlD
Pomalidomide—ABCB1—retina—malignant glioma	0.000233	0.0158	CbGeAlD
Pomalidomide—ABCB1—telencephalon—malignant glioma	0.000215	0.0145	CbGeAlD
Pomalidomide—PTGS2—central nervous system—malignant glioma	0.000197	0.0134	CbGeAlD
Pomalidomide—PTGS2—cerebellum—malignant glioma	0.000193	0.0131	CbGeAlD
Pomalidomide—CYP3A4—central nervous system—malignant glioma	0.000172	0.0117	CbGeAlD
Pomalidomide—ABCB1—medulla oblongata—malignant glioma	0.000169	0.0114	CbGeAlD
Pomalidomide—PTGS2—brain—malignant glioma	0.000157	0.0106	CbGeAlD
Pomalidomide—ABCB1—midbrain—malignant glioma	0.000154	0.0104	CbGeAlD
Pomalidomide—ABCB1—spinal cord—malignant glioma	0.00015	0.0102	CbGeAlD
Pomalidomide—ABCB1—central nervous system—malignant glioma	0.000122	0.00827	CbGeAlD
Pomalidomide—ABCB1—cerebellum—malignant glioma	0.000119	0.00808	CbGeAlD
Pomalidomide—ABCB1—brain—malignant glioma	9.69e-05	0.00656	CbGeAlD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	4.42e-05	0.000476	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—EGFR—malignant glioma	4.41e-05	0.000475	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—TNF—malignant glioma	4.35e-05	0.000469	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	4.35e-05	0.000468	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	4.35e-05	0.000468	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—PTGS1—malignant glioma	4.3e-05	0.000463	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—COX8A—malignant glioma	4.23e-05	0.000456	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	4.18e-05	0.00045	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—RTEL1—malignant glioma	4.17e-05	0.000449	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—KRAS—malignant glioma	4.16e-05	0.000448	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	4.14e-05	0.000446	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	4.14e-05	0.000446	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—GSTP1—malignant glioma	4.12e-05	0.000444	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	4.11e-05	0.000442	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	4.06e-05	0.000438	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	4.06e-05	0.000438	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—BCAN—malignant glioma	4.04e-05	0.000435	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—FGFR1—malignant glioma	3.98e-05	0.000429	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.98e-05	0.000428	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—TP53—malignant glioma	3.95e-05	0.000425	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—VEGFA—malignant glioma	3.92e-05	0.000423	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	3.85e-05	0.000414	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.78e-05	0.000407	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.76e-05	0.000405	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—KDR—malignant glioma	3.75e-05	0.000404	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	3.73e-05	0.000402	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—TP53—malignant glioma	3.7e-05	0.000399	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—MYC—malignant glioma	3.7e-05	0.000398	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—MET—malignant glioma	3.67e-05	0.000395	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	3.65e-05	0.000393	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—DTX1—malignant glioma	3.65e-05	0.000393	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—AKT1—malignant glioma	3.63e-05	0.000392	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—EGFR—malignant glioma	3.61e-05	0.000389	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	3.6e-05	0.000388	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ASMT—malignant glioma	3.6e-05	0.000387	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	3.59e-05	0.000386	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	3.55e-05	0.000382	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—NOTCH1—malignant glioma	3.53e-05	0.000381	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.51e-05	0.000379	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	3.45e-05	0.000372	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TNF—malignant glioma	3.44e-05	0.000371	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—PTPN11—malignant glioma	3.39e-05	0.000366	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—BCAN—malignant glioma	3.38e-05	0.000364	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—TNF—malignant glioma	3.36e-05	0.000362	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	3.34e-05	0.00036	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	3.34e-05	0.00036	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—PPARG—malignant glioma	3.33e-05	0.000359	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—AKT1—malignant glioma	3.33e-05	0.000359	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	3.24e-05	0.000349	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	3.22e-05	0.000347	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—RTEL1—malignant glioma	3.22e-05	0.000346	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	3.2e-05	0.000345	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—GSTP1—malignant glioma	3.18e-05	0.000343	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—AKT2—malignant glioma	3.16e-05	0.000341	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	3.14e-05	0.000338	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—AKT1—malignant glioma	3.12e-05	0.000337	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—MMP2—malignant glioma	3.06e-05	0.00033	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TP53—malignant glioma	3.03e-05	0.000327	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	3.03e-05	0.000326	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—COX8A—malignant glioma	3e-05	0.000323	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	2.98e-05	0.000321	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—FGF2—malignant glioma	2.91e-05	0.000313	CbGpPWpGaD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	2.89e-05	0.000312	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	2.88e-05	0.00031	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HEY2—malignant glioma	2.86e-05	0.000309	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.82e-05	0.000304	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IDH1—malignant glioma	2.8e-05	0.000301	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	2.73e-05	0.000294	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	2.73e-05	0.000294	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—IDH2—malignant glioma	2.72e-05	0.000294	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—RAF1—malignant glioma	2.71e-05	0.000292	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—ERBB2—malignant glioma	2.68e-05	0.000289	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HEY1—malignant glioma	2.65e-05	0.000286	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	2.59e-05	0.000279	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HIST1H3B—malignant glioma	2.58e-05	0.000278	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.57e-05	0.000277	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP2B6—malignant glioma	2.56e-05	0.000276	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	2.55e-05	0.000275	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ASMT—malignant glioma	2.55e-05	0.000275	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	2.55e-05	0.000275	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	2.54e-05	0.000274	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	2.51e-05	0.000271	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	2.51e-05	0.000271	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	2.46e-05	0.000265	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.46e-05	0.000265	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—BCAN—malignant glioma	2.4e-05	0.000258	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—COX8A—malignant glioma	2.39e-05	0.000258	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—JAG2—malignant glioma	2.35e-05	0.000253	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—IDH1—malignant glioma	2.34e-05	0.000252	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.34e-05	0.000252	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	2.34e-05	0.000252	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.32e-05	0.00025	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—MMP9—malignant glioma	2.3e-05	0.000248	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	2.28e-05	0.000246	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SPHK1—malignant glioma	2.27e-05	0.000244	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	2.23e-05	0.00024	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP2C18—malignant glioma	2.22e-05	0.000239	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	2.14e-05	0.000231	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.14e-05	0.00023	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.13e-05	0.00023	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.09e-05	0.000226	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—VEGFA—malignant glioma	2.07e-05	0.000223	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.06e-05	0.000222	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—STAT3—malignant glioma	2.05e-05	0.00022	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ASMT—malignant glioma	2.03e-05	0.000219	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—H3F3A—malignant glioma	1.99e-05	0.000214	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.99e-05	0.000214	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	1.94e-05	0.000209	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—IDH2—malignant glioma	1.93e-05	0.000208	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—BCAN—malignant glioma	1.91e-05	0.000206	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.91e-05	0.000206	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—JAG1—malignant glioma	1.88e-05	0.000202	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—EGFR—malignant glioma	1.86e-05	0.0002	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—COX8A—malignant glioma	1.85e-05	0.000199	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.84e-05	0.000198	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—FBXW7—malignant glioma	1.84e-05	0.000198	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP2B6—malignant glioma	1.82e-05	0.000196	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTT1—malignant glioma	1.8e-05	0.000194	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	1.78e-05	0.000192	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—KRAS—malignant glioma	1.76e-05	0.000189	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.74e-05	0.000188	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	1.74e-05	0.000188	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PTGS1—malignant glioma	1.68e-05	0.000181	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.68e-05	0.000181	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—IDH1—malignant glioma	1.66e-05	0.000179	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	1.66e-05	0.000179	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	1.65e-05	0.000177	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SPHK1—malignant glioma	1.61e-05	0.000173	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP2C18—malignant glioma	1.57e-05	0.00017	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ASMT—malignant glioma	1.57e-05	0.000169	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—BCHE—malignant glioma	1.56e-05	0.000169	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SLC5A5—malignant glioma	1.55e-05	0.000167	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—IDH2—malignant glioma	1.54e-05	0.000166	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.51e-05	0.000163	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—BCAN—malignant glioma	1.48e-05	0.000159	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.46e-05	0.000158	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.46e-05	0.000158	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.45e-05	0.000157	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.45e-05	0.000156	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CDKN2B—malignant glioma	1.44e-05	0.000155	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HES1—malignant glioma	1.37e-05	0.000148	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NCOR1—malignant glioma	1.37e-05	0.000147	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—IDH1—malignant glioma	1.33e-05	0.000143	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—AKT1—malignant glioma	1.32e-05	0.000142	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PDGFRA—malignant glioma	1.31e-05	0.000141	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SPHK1—malignant glioma	1.28e-05	0.000138	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTT1—malignant glioma	1.27e-05	0.000137	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.26e-05	0.000136	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP2C18—malignant glioma	1.26e-05	0.000135	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTP1—malignant glioma	1.25e-05	0.000134	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.24e-05	0.000133	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CAT—malignant glioma	1.21e-05	0.000131	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HLA-A—malignant glioma	1.2e-05	0.00013	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TERT—malignant glioma	1.2e-05	0.00013	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGS1—malignant glioma	1.19e-05	0.000129	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—IDH2—malignant glioma	1.19e-05	0.000128	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.19e-05	0.000128	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PDGFB—malignant glioma	1.18e-05	0.000127	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—FGFR1—malignant glioma	1.17e-05	0.000126	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HIF1A—malignant glioma	1.15e-05	0.000124	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NCOR1—malignant glioma	1.14e-05	0.000123	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.12e-05	0.000121	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CAV1—malignant glioma	1.11e-05	0.00012	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—BCHE—malignant glioma	1.11e-05	0.00012	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC5A5—malignant glioma	1.1e-05	0.000118	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.08e-05	0.000116	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—BAD—malignant glioma	1.05e-05	0.000113	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.04e-05	0.000112	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOTCH1—malignant glioma	1.04e-05	0.000112	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—IDH1—malignant glioma	1.02e-05	0.00011	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTT1—malignant glioma	1.02e-05	0.00011	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CD80—malignant glioma	1.02e-05	0.00011	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APC—malignant glioma	1.01e-05	0.000109	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.01e-05	0.000109	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—EGF—malignant glioma	1e-05	0.000108	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PTPN11—malignant glioma	9.97e-06	0.000107	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SPHK1—malignant glioma	9.9e-06	0.000107	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP2C18—malignant glioma	9.7e-06	0.000105	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—BRAF—malignant glioma	9.54e-06	0.000103	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGS1—malignant glioma	9.53e-06	0.000103	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.49e-06	0.000102	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CAV1—malignant glioma	9.33e-06	0.000101	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—AKT2—malignant glioma	9.28e-06	0.0001	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PIK3CD—malignant glioma	8.92e-06	9.61e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.91e-06	9.6e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—BCHE—malignant glioma	8.86e-06	9.54e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTP1—malignant glioma	8.83e-06	9.51e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC5A5—malignant glioma	8.75e-06	9.43e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CAT—malignant glioma	8.59e-06	9.26e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—FGF2—malignant glioma	8.54e-06	9.2e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3CG—malignant glioma	8.5e-06	9.16e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.27e-06	8.91e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPARG—malignant glioma	8.2e-06	8.84e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.2e-06	8.83e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NCOR1—malignant glioma	8.11e-06	8.74e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MDM2—malignant glioma	7.99e-06	8.61e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—RAF1—malignant glioma	7.96e-06	8.58e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ERBB2—malignant glioma	7.88e-06	8.49e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTT1—malignant glioma	7.85e-06	8.45e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PIK3CB—malignant glioma	7.77e-06	8.38e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3CD—malignant glioma	7.47e-06	8.05e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGS1—malignant glioma	7.35e-06	7.92e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.15e-06	7.7e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTP1—malignant glioma	7.05e-06	7.59e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CAT—malignant glioma	6.86e-06	7.39e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—BCHE—malignant glioma	6.83e-06	7.36e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC5A5—malignant glioma	6.75e-06	7.27e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PTEN—malignant glioma	6.72e-06	7.24e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CAV1—malignant glioma	6.61e-06	7.12e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3CB—malignant glioma	6.51e-06	7.02e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NCOR1—malignant glioma	6.48e-06	6.98e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3CG—malignant glioma	6.02e-06	6.49e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—STAT3—malignant glioma	6.01e-06	6.47e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPARG—malignant glioma	5.81e-06	6.26e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PTEN—malignant glioma	5.63e-06	6.06e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MYC—malignant glioma	5.58e-06	6.02e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—EGFR—malignant glioma	5.46e-06	5.88e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTP1—malignant glioma	5.44e-06	5.86e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3CD—malignant glioma	5.29e-06	5.71e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CAT—malignant glioma	5.29e-06	5.7e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CAV1—malignant glioma	5.28e-06	5.69e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—KRAS—malignant glioma	5.16e-06	5.56e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.04e-06	5.43e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NCOR1—malignant glioma	5e-06	5.38e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3CG—malignant glioma	4.81e-06	5.18e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PIK3CA—malignant glioma	4.74e-06	5.11e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPARG—malignant glioma	4.64e-06	5e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3CB—malignant glioma	4.61e-06	4.97e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGS2—malignant glioma	4.57e-06	4.93e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3CD—malignant glioma	4.23e-06	4.55e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CAV1—malignant glioma	4.07e-06	4.39e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTEN—malignant glioma	3.99e-06	4.3e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3CA—malignant glioma	3.97e-06	4.28e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—AKT1—malignant glioma	3.87e-06	4.17e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.71e-06	4e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3CB—malignant glioma	3.68e-06	3.97e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGS2—malignant glioma	3.65e-06	3.93e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPARG—malignant glioma	3.58e-06	3.86e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.26e-06	3.52e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AKT1—malignant glioma	3.24e-06	3.49e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTEN—malignant glioma	3.18e-06	3.43e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.84e-06	3.06e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGS2—malignant glioma	2.82e-06	3.04e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3CA—malignant glioma	2.81e-06	3.03e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTEN—malignant glioma	2.46e-06	2.65e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AKT1—malignant glioma	2.3e-06	2.48e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3CA—malignant glioma	2.25e-06	2.42e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AKT1—malignant glioma	1.83e-06	1.98e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.73e-06	1.87e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AKT1—malignant glioma	1.42e-06	1.53e-05	CbGpPWpGaD
